News Releases

Omnicell Announces its First Robotic Dispensing System Installation in the Middle East
System will be showcased at Arab Health Congress in Dubai January 25-28

MOUNTAIN VIEW, Calif., Jan. 27, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for health care facilities, is installing its first robotic dispensing system in the Middle East after winning a contract and expanding its current relationship with Hamad Medical Cooperation in Qatar. Hamad Medical Cooperation and Omnicell expect the Omnicell robotic dispensing system to be fully operational at The General Hospital, the country's main hospital, next month.

Omnicell, Inc. logo

The decision to install an Omnicell robotic dispensing system was a natural step in the continuum of care for Hamad Medical Cooperation, which already uses Omnicell automation systems and other solutions in some of their other health care facilities.

Engineered in Germany, Omnicell's robotic dispensing system is a market leader for quantity of patient packs dispensed every hour in original manufacturers' packages. It serves the needs of a broad spectrum of pharmacy customers, from large hospital outpatient systems to local community pharmacies. The flexible design is optimized for high capacity storage and speed of delivery in a minimum amount of physical space. The system will be just one of the Omnicell products on display at the Arab Health Congress taking place in Dubai January 25-28.

Omnicell was selected over other vendors by Hamad Medical Corporation due to its speed in delivery of patient medication packs, the flexibility in configurations to meet the needs of the outpatient pharmacy and the strong regional support for the Omnicell product lines.

"We are very pleased that our robotic dispensing solution has been chosen by one of the largest health systems in the Middle East. Omnicell's robotic systems can be configured to suit each specific customer's needs, which is a unique advantage over other systems. As a result we have been able to work closely with Hamad Medical Corporation to develop the solution that works best for them and meets their requirements," said Baha El Mahgoub, Omnicell's General Manager for Middle East and Africa.

El Mahgoub added, "We've been working alongside our local business partner in Qatar, Gateway, and installation of the system is now almost complete. We are looking forward to seeing it fully operational next month. We believe this will be the first of many Omnicell robotic dispensing systems installed in the Middle East in the very near future."

"The Omnicell robotic dispensing system was selected due to its fast dispensing capability, ability to provide up to 1200 patients medications per day, secure storage of costly and controlled drugs and bar code verification capability for patient medications.  While the implementation is still ongoing, our experience with the Omnicell robot and installation process has been excellent thus far," stated the Pharmacy Project Coordinator, HGH Director of Pharmacy and Assistant Director at Hamad Medical Corporation, Doha, Qatar.

For those Attending Arab Health

The Omnicell robotic dispensing system will be exhibited at Arab Health this week on stand 2D-10 in Hall 2. Omnicell will be demonstrating its total health care solution at the exhibition, from medication adherence packaging and solutions to hospital automation and analytics. Omnicell products can be used from the hospital to home.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Approximately 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design, are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo -


SOURCE Omnicell, Inc.

For further information: Baha El Mahgoub, Omnicell, Inc., General Manager for Middle East and Africa, +971 4 454 8734,